Docoh
Loading...

CNTB Connect Biopharma

News

From Benzinga Pro
Connect Biopharma's Latest Dermatitis Drug Update Fails to Pump Up Shares
13 Jan 22
Biotech, General
Key takeaways: Loss-making Connect Biopharma says Phase 3 clinical trials of its CBP-201 drug for atopic dermatitis will begin in second half of this year Connect Biopharma shares, which more than halved after its November release of initial Phase 2 clinical trial data, fell further after latest update By Mia Shanley
58 Biggest Movers From Yesterday
7 Jan 22
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Eargo, Inc. (NASDAQ: EAR) shares climbed 59.7% to close at $7.28 on Thurs after the company announced the Department of Justice confirmed to it that the previously-announced criminal probe is no long active.
33 Stocks Moving In Thursday's Mid-Day Session
6 Jan 22
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers Eargo, Inc. (NASDAQ: EAR) shares jumped 50.8% to $6.88 after the company announced the Department of Justice confirmed to it that the previously-announced criminal probe is no long active.
10 Biggest Price Target Changes For Thursday
6 Jan 22
Price Target, Small Cap, Pre-Market Outlook, Analyst Ratings
JP Morgan raised the price target for RPM International Inc. (NYSE: RPM) from $85 to $100. RPM shares rose 0.5% to $97.90 in pre-market trading.
23 Stocks Moving in Thursday's Pre-Market Session
6 Jan 22
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) rose 54.3% to $0.9490 in pre-market trading after declining more than 11% on Wednesday.
50 Biggest Movers From Yesterday
6 Jan 22
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers
SVB Leerink Maintains Outperform on Connect Biopharma Hldgs, Lowers Price Target to $22
6 Jan 22
News, Price Target, Analyst Ratings
SVB Leerink analyst Thomas Smith maintains Connect Biopharma Hldgs (NASDAQ:CNTB) with a Outperform and lowers the price target from $32 to $22.
34 Stocks Moving In Wednesday's Mid-Day Session
5 Jan 22
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers Mainz Biomed B.V. (NASDAQ: MYNZ) shares climbed 49.7% to $15.45 after the company announced it acquired exclusive rights to novel mRNA biomarkers.
The Daily Biotech Pulse: Pfizer-BioNTech Partner For Shingles Vaccine, Annexon Huntington Disease Study Disappoints, Amneal Buys Neurology Assets
5 Jan 22
Biotech, News, Penny Stocks, Guidance, Financing, Small Cap, FDA, General
Here's a roundup of top developments in the biotech space over the last 24 hours.
Connect Biopharma Reports Detailed Dataset From Global Phase 2b Trial Of CBP-201 In Adult Patients With Moderate-To-Severe Atopic Dermatitis
5 Jan 22
Biotech, General
—Phase 2b trial previously reported achievement of both primary and key secondary end points, demonstrating significant improvements in skin clearance, disease severity, and itch compared to
52 Biggest Movers From Friday
22 Nov 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Greenland Technologies Holding Corporation (NASDAQ: GTEC) shares surged 90.2% to close at $9.89 on Friday. Greenland Technologies highlighted the launch of second electric industrial vehicle line: GEL-1800 Front Loader.
The Week Ahead In Biotech (Nov. 21-Nov. 27): Takeda, Aadi, Fennec FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week
21 Nov 21
Biotech, Earnings, News, Penny Stocks, Small Cap, Top Stories, General
Biotech stocks showed a lack of direction in the week ending Nov. 19 before finishing modestly higher. Stocks did not have much meaningful catalysts to react to amid the winding down of the reporting season and ahead of the holiday week.
Mid-Afternoon Market Update: Dow Falls 200 Points; Connect Biopharma Shares Tumble
19 Nov 21
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets
Toward the end of trading Friday, the Dow traded down 0.58% to 35,664.58 while the NASDAQ rose 0.53% to 16,078.19. The S&P also rose, gaining 0.05% to 4,706.69.
Mid-Day Market Update: Crude Oil Down Over 4%; UWM Holdings Shares Surge
19 Nov 21
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets
Midway through trading Friday, the Dow traded down 0.62% to 35,648.81 while the NASDAQ rose 0.53% to 16,078.23. The S&P also fell, dropping 0.01% to 4,704.35.
33 Stocks Moving In Friday's Mid-Day Session
19 Nov 21
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers Greenland Technologies Holding Corporation (NASDAQ: GTEC) shares jumped 75.4% to $9.17. Greenland Technologies highlighted the launch of second electric industrial vehicle line: GEL-1800 Front Loader.
Mid-Morning Market Update: Markets Mixed; Foot Locker Profit Beats Views
19 Nov 21
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets
Following the market opening Friday, the Dow traded down 0.66% to 35,634.40 while the NASDAQ rose 0.54% to 16,079.51. The S&P also fell, dropping 0.03% to 4,703.27.
The Daily Biotech Pulse: Connect Biopharma Sinks On Eczema Drug Readout, Enanta Pulls Plug On HBV Drug, Clinical Setback For Merck In HIV Trial
19 Nov 21
Biotech, News, Penny Stocks, Offerings, Small Cap, FDA, General
Here's a roundup of top developments in the biotech space over the last 24 hours:
Connect Biopharma's Mid-Stage Atopic Dermatitis Trial Meets Primary Endpoint
19 Nov 21
Biotech, News, Health Care, Small Cap, Movers, Trading Ideas, General
20 Stocks Moving in Friday's Pre-Market Session
19 Nov 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Mammoth Energy Services, Inc. (NASDAQ: TUSK) rose 29.9% to $2.87 in pre-market trading after the company announced a multi-year electric vehicle charging station engineering contract.
Connect Biopharma Reports Top-Line Results From Global Phase 2 Trial Of CBP-201 In Patients With Moderate-To-Severe Atopic Dermatitis: Primary Endpoint Met
18 Nov 21
Biotech, News, FDA, General
Primary endpoint met with all three CBP-201 arms achieving significant improvements Significant improvements also reported for key secondary endpoints including other measures of skin clearance and itch with CBP-201

Press releases

From Benzinga Pro
Thinking about buying stock in Longeveron, Senseonics, Connect Biopharma, Wejo Group, or Energous Corp?
5 Jan 22
Opinion, Press Releases
NEW YORK, Jan. 5, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for LGVN, SENS, CNTB, WEJO, and WATT.
Connect Biopharma to Host Conference Call on January 5 at 8:30 AM ET to Review Detailed Data from the Global Phase 2b Trial of CBP-201
4 Jan 22
News, Press Releases
SAN DIEGO and TAICANG, China, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (NASDAQ:CNTB) ("Connect Biopharma" or the "Company"), a global clinical-stage biopharmaceutical company
Amberstone Biosciences Secures $12 Million Series A Financing to Advance Immuno-Oncology Pipeline of Tumor Microenvironment Activated Therapeutics
3 Jan 22
Press Releases
Amberstone Biosciences (www.amberstonebio.com), an emerging biotherapeutics company with unique expertise in conditionally active immunotherapeutics, today announced the completion of a $12 million Series A financing
Connect Biopharma Expands Executive Leadership Team with Hire of Chief Financial Officer
22 Nov 21
News, Management, Press Releases
SAN DIEGO, CA and TAICANG, SUZHOU, China, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (NASDAQ:CNTB) ("Connect Biopharma" or the "Company"), a global clinical-stage biopharmaceutical
Connect Biopharma Reports Positive Top-Line Results from the Global Phase 2 Clinical Trial of CBP-201 in Patients with Moderate-to-Severe Atopic Dermatitis
18 Nov 21
Health Care, Press Releases, General
Primary endpoint met with all three CBP-201 arms achieving significant improvements Significant improvements also reported for key secondary endpoints including other measures of skin clearance and itch with CBP-201
Connect Biopharma to Participate at Upcoming Conferences
11 Nov 21
News, Press Releases
SAN DIEGO, CA and TAICANG, SUZHOU, China, Nov. 11, 2021 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (NASDAQ:CNTB) ("Connect Biopharma" or the "Company"), a global clinical-stage biopharmaceutical company